The recent merger of Aphria and Tilray (NASDAQ: TLRY) created a Canadian cannabis juggernaut. In this Motley Fool Live video recorded on June 11, healthcare and cannabis bureau editor Olivia Zitkus and Motley Fool contributor Keith Speights discuss how strong Tilray is after its merger with Aphria. Olivia Zitkus: Let's dive into some deals, Keith, if you feel good about that.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting